Cobalt and GlaxoSmithKline Finally Reach Settlement

Michael Coyle
February 26, 2007

It was announced on 15 November 2006 that Cobalt Laboratories Inc. has reached a patent litigation settlement with GlaxoSmithKline Plc. regarding its Âsumatriptan succinate tabletsÂ, the generic version of GlaxoSmithKline’s Imitrex, which is sold to treat migraine pain.

Cobalt Pharmaceuticals Inc. announced in a statement that the company may distribute a genericÂ version in the U.S. by the first quarter of 2009 following the settlement which remains subject toÂ government review.

This was just one term that was agreed between lawyers, but the statement did not provideÂ additional details on the other terms of the settlement.

share this Article

Recent Articles

Primark is refusing to join the e-commerce market.

Fashion retailer, Primark, has already established a loyal customer base when it comes to their physical stores. However, as a result of the pandemic, many

Tips for engaging with customers before you launch your e-commerce brand.

Marketing your upcoming business before it has launched is a crucial factor that can set the tone and accelerate your brand’s image. A pre-launch campaign

Bentley Motors vs Bentley Clothing: a trade mark dispute

Back in 2019, a High Court ruling held that luxury car maker, Bentley, had infringed on the rights of Bentley Clothing, a fashion company based

Cypriot business cheesed off after ‘BBQloumi’ trade mark loss

After ups and downs, the Foundation for the Protection of the Traditional Cheese of Cyprus named Halloumi has failed to stop a rival protecting the

Need Legal Advice? Book a Free Consultation

Lawdit ® Solicitors is the trading name of Lawdit Solicitors Ltd. Regulated by the Solicitors Regulation Authority of England and Wales.

Southampton Office

Isle of Wight Office

Quick Links

Lawdit ® Solicitors © 2021. All Rights Reserved.

Website by Nosy.Marketing